1. Home
  2. ABP vs LODE Comparison

ABP vs LODE Comparison

Compare ABP & LODE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABP
  • LODE
  • Stock Information
  • Founded
  • ABP 2004
  • LODE 2008
  • Country
  • ABP United States
  • LODE United States
  • Employees
  • ABP N/A
  • LODE N/A
  • Industry
  • ABP Biotechnology: Pharmaceutical Preparations
  • LODE Major Chemicals
  • Sector
  • ABP Health Care
  • LODE Industrials
  • Exchange
  • ABP Nasdaq
  • LODE Nasdaq
  • Market Cap
  • ABP 76.2M
  • LODE 79.6M
  • IPO Year
  • ABP N/A
  • LODE N/A
  • Fundamental
  • Price
  • ABP $0.84
  • LODE $0.29
  • Analyst Decision
  • ABP
  • LODE Buy
  • Analyst Count
  • ABP 0
  • LODE 1
  • Target Price
  • ABP N/A
  • LODE $2.60
  • AVG Volume (30 Days)
  • ABP 38.3K
  • LODE 5.7M
  • Earning Date
  • ABP 02-28-2025
  • LODE 03-03-2025
  • Dividend Yield
  • ABP N/A
  • LODE N/A
  • EPS Growth
  • ABP N/A
  • LODE N/A
  • EPS
  • ABP N/A
  • LODE N/A
  • Revenue
  • ABP $230,000.00
  • LODE $1,864,811.00
  • Revenue This Year
  • ABP N/A
  • LODE $69.41
  • Revenue Next Year
  • ABP N/A
  • LODE $56.83
  • P/E Ratio
  • ABP N/A
  • LODE N/A
  • Revenue Growth
  • ABP N/A
  • LODE 117.46
  • 52 Week Low
  • ABP $0.80
  • LODE $0.13
  • 52 Week High
  • ABP $13.00
  • LODE $1.01
  • Technical
  • Relative Strength Index (RSI)
  • ABP N/A
  • LODE 35.36
  • Support Level
  • ABP N/A
  • LODE $0.28
  • Resistance Level
  • ABP N/A
  • LODE $0.41
  • Average True Range (ATR)
  • ABP 0.00
  • LODE 0.03
  • MACD
  • ABP 0.00
  • LODE -0.01
  • Stochastic Oscillator
  • ABP 0.00
  • LODE 4.85

About ABP Abpro Holdings Inc Common Stock

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with global pharmaceutical and research institutions.

About LODE Comstock Inc.

Comstock Inc is engaged in technologies that efficiently use wasted and under-utilized natural resources to produce renewable energy and other products that contribute to balancing uses and emissions of carbon and enhance mineral and material discoveries. The segments of the company are Fuels Metals, Mining, Strategic Investments, and Corporate. The company derives maximum revenue from Strategic Investments segment. The Strategic Investments Segment includes minority equity investments in Quantum Generative Materials LLC (physics-based artificial intelligence), Green Li-ion Pte Limited (lithium-ion battery recycling and cathode production), Sierra Springs Opportunity Fund (strategic direct investment in northern Nevada real estate), and other equity or equity-linked investments.

Share on Social Networks: